Publications
Contact
FR

Products
- PRESCRIPTION
  - TH07
- DRUG-FREE
  - TH16
- RIZN
- Plenty Natural
Company
Science
Investors
Clinical trials

Products
Company
Science
Investors
Clinical trials

RIZN

Search

Search

Recent Posts

Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India
Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia
Triple Hair’s Feature in the NY Post
Triple Hair Group Signs Licensing Agreement for the Brazilian Market with Aché
Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of Directors

Recent Comments

Triple Hair is a clinical-stage Canadian
biotechnology company specialized in the
development of innovative treatments for alopecia.

Revolutionary
hair growth
therapies

Company
Products
TH07
Science
Contact
TH16
Investors
Terms and Conditions
Privacy Policy

Copyright © 2020 | Triple Hair

Clinical Trials

Looking to invest?